Intelligent Bio Solutions Inc. (INBS) Receivables (2021 - 2025)
Intelligent Bio Solutions (INBS) posted quarterly Receivables of $614613.0 for Q2 2025, up 38.81% year-over-year from $442777.0 in Q2 2024, and up 20.29% quarter-over-quarter from $510963.0 in Q1 2025.
Intelligent Bio Solutions Inc. (INBS) Receivables (2021 - 2025) Analysis & Trends
Intelligent Bio Solutions' Receivables history runs 5 years deep, the most recent figure standing at $614613.0 for Q2 2025.
- In Q2 2025, Receivables rose 38.81% year-over-year to $614613.0; the TTM figure through Jun 2025 stood at $614613.0 (up 38.81% YoY), while the FY2025 annual figure was $615159.0, up 38.93% from the prior year.
- Receivables for Q2 2025 stood at $614613.0, up from $510963.0 in the prior quarter.
- The five-year high for Receivables was $2.1 million in Q2 2021, with the low at $262834.0 in Q4 2023.
- The 5-year median for Receivables is $573044.0 (2023), against an average of $898717.4.
- The sharpest annual moves came in 2023 and 2024: Receivables sank 83.37% in 2023, then surged 45.8% in 2024.
- Intelligent Bio Solutions' Receivables stood at $1.6 million in 2021, then declined by 4.38% to $1.6 million in 2022, then tumbled by 83.23% to $262834.0 in 2023, then climbed by 1.24% to $266080.0 in 2024, then soared by 130.99% to $614613.0 in 2025.
- Business Quant data shows INBS's Receivables at $614613.0 in Q2 2025, $510963.0 in Q1 2025, and $266080.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 614,613.00 |
| Mar 31, 2025 | 510,963.00 |
| Dec 31, 2024 | 266,080.00 |
| Sep 30, 2024 | 578,578.00 |
| Jun 30, 2024 | 442,777.00 |
| Mar 31, 2024 | 431,646.00 |
| Dec 31, 2023 | 262,834.00 |
| Sep 30, 2023 | 567,510.00 |
| Jun 30, 2023 | 313,988.00 |
| Mar 31, 2023 | 296,049.00 |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Jun 30, 2021 | 2.10 Mn |